NL6704539A - - Google Patents

Info

Publication number
NL6704539A
NL6704539A NL6704539A NL6704539A NL6704539A NL 6704539 A NL6704539 A NL 6704539A NL 6704539 A NL6704539 A NL 6704539A NL 6704539 A NL6704539 A NL 6704539A NL 6704539 A NL6704539 A NL 6704539A
Authority
NL
Netherlands
Application number
NL6704539A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6704539A publication Critical patent/NL6704539A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL6704539A 1966-04-01 1967-03-30 NL6704539A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEF0048833 1966-04-01

Publications (1)

Publication Number Publication Date
NL6704539A true NL6704539A (fr) 1967-10-02

Family

ID=7102516

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6704539A NL6704539A (fr) 1966-04-01 1967-03-30

Country Status (9)

Country Link
US (1) US3538097A (fr)
BE (1) BE696499A (fr)
CH (2) CH533124A (fr)
DE (1) DE1670684A1 (fr)
FR (2) FR1519964A (fr)
GB (1) GB1186723A (fr)
MY (1) MY7100120A (fr)
NL (1) NL6704539A (fr)
OA (1) OA02583A (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4091101A (en) * 1977-06-15 1978-05-23 Merck & Co., Inc. 6-(1-Piperazinyl)quinoxaline
DE3611343A1 (de) * 1986-04-04 1987-10-08 Boehringer Mannheim Gmbh Heterocyclisch substituierte benzimidazole, verfahren zu ihrer herstellung, arzneimittel sowie zwischenprodukte
EP0777656B1 (fr) * 1994-08-26 2004-04-14 Auckland Division Cancer Society Of New Zealand (Incorporated) Nouveaux agents d'alkilation cibles sur l'adn
AU695936B2 (en) * 1994-08-26 1998-08-27 Auckland Division Cancer Society Of New Zealand Inc Novel dna-targeted alkylating agents
US5767142A (en) * 1996-03-20 1998-06-16 Rutgers, The State University Of New Jersey Trisbenzimidazoles useful as topoisomerase I inhibitors
US5807874A (en) * 1995-05-17 1998-09-15 Rutgers, The State University Of New Jersey Trisbenzimidazoles useful as topoisomerase I inhibitors
AUPN449295A0 (en) 1995-07-28 1995-08-24 Inner And Eastern Health Care Network, The Radioprotectors
JP2001501197A (ja) * 1996-09-23 2001-01-30 ルトガーズ，ザ ステイト ユニバーシティ オブ ニュージャージー 抗―腫瘍剤としての置換された複素環式化合物類
US6140328A (en) 1997-12-12 2000-10-31 Rutgers, The State University Of New Jersey Heterocyclic cytotoxic agents
PL341539A1 (en) * 1997-12-31 2001-04-23 Rutgers Heterocyclic toxins of topoisomerases
US6063801A (en) 1998-02-12 2000-05-16 Rutgers, The State University Of New Jersey Heterocyclic topoisomerase poisons
US6740650B2 (en) 1999-10-29 2004-05-25 Rutgers, The State University Of New Jersey Heterocyclic cytotoxic agents
EP1453812B1 (fr) 2001-11-14 2008-08-20 Rutgers, The State University Agents cytotoxiques
WO2003047505A2 (fr) * 2001-11-14 2003-06-12 Rutgers, The State University Agents toxiques de topoisomerase
WO2003041660A2 (fr) * 2001-11-14 2003-05-22 Rutgers, The State University Poisons de topoisomerase solubilises
EP1453507B1 (fr) * 2001-11-14 2009-03-04 Rutgers, The State University Agents poisons de topoisomerases solubilises
US20050119251A1 (en) * 2001-12-21 2005-06-02 Jian-Min Fu Nicotinamide derivatives and their use as therapeutic agents
AU2003268075A1 (en) * 2002-08-09 2004-02-25 Edmond J. Lavoie Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents
WO2004014918A1 (fr) 2002-08-09 2004-02-19 Rutgers, The State University Agents de la topoisomerase substitues par nitro et amino
WO2004014862A1 (fr) * 2002-08-09 2004-02-19 Rutgers, The State University Heterocycles a substitution nitro et amino utiles en tant qu'agents de ciblage de la topoisomerase i
CA2510337C (fr) * 2002-11-12 2013-01-08 Rutgers, The State University Of New Jersey Agents ciblant les topoisomerases
US8071603B2 (en) 2004-09-20 2011-12-06 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
US7592343B2 (en) * 2004-09-20 2009-09-22 Xenon Pharmaceuticals Inc. Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors
BRPI0611187A2 (pt) * 2005-06-03 2010-08-24 Xenon Pharmaceuticals Inc derivados aminotiazàis como inibidores da estearoil-coa desaturase humana
JP5639763B2 (ja) * 2006-12-21 2014-12-10 ピーター・マッカラム・キャンサー・インスティチュート 放射線防護剤および関連する方法
GB0821913D0 (en) 2008-12-02 2009-01-07 Price & Co Antibacterial compounds
PT2403856E (pt) 2009-03-06 2013-03-25 Univ Rutgers Derivados de metilendioxibenzo[i]fenantridina utilizados para tratar o cancro
WO2010127363A1 (fr) 2009-05-01 2010-11-04 Rutgers, The State University Of New Jersey Inhibiteurs de topoisomérase
JP5712524B2 (ja) * 2009-10-28 2015-05-07 Jsr株式会社 液晶配向剤および液晶表示素子
WO2011151621A1 (fr) * 2010-06-01 2011-12-08 Summit Corporation Plc Composés pour le traitement d'une maladie associée à clostridium difficile
JP6463631B2 (ja) * 2011-06-09 2019-02-06 ライゼン・ファーマシューティカルズ・エスアー Ｇｐｒ−１１９のモジュレータとしての新規化合物
GB201506658D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
GB201506660D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
CA3011672C (fr) * 2016-01-23 2022-11-01 Vibha Tandon Activite antibacterienne a large spectre de bisbenzimidazoles ciblant latopoisomerase ia
CN109219610A (zh) 2016-04-04 2019-01-15 新泽西州立拉特格斯大学 拓扑异构酶毒物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3103403A (en) * 1963-09-10 Dyeing of polyester fibers with com-
US2980690A (en) * 1957-08-30 1961-04-18 Ciba Pharm Prod Inc New basically substituted benzylbenzimidazoles
US3072661A (en) * 1960-08-24 1963-01-08 Interchem Corp New process for improved bis-imidazole vat dyestuff pigments
US3133056A (en) * 1961-05-15 1964-05-12 May & Baker Ltd N-phenylpiperazine derivatives of tetrahydrobenzodiazepines
NL128199C (fr) * 1962-04-21
NL135043C (fr) * 1963-10-11
GB1122988A (en) * 1964-10-22 1968-08-07 Fisons Pest Control Ltd Benzimidazole derivatives
US3336191A (en) * 1966-03-11 1967-08-15 Smith Kline French Lab Anthelmintic 2-amidobenzimidazoles
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines

Also Published As

Publication number Publication date
OA02583A (fr) 1970-05-05
FR6681M (fr) 1969-02-03
BE696499A (fr) 1967-10-03
CH525902A (de) 1972-07-31
MY7100120A (en) 1971-12-31
US3538097A (en) 1970-11-03
FR1519964A (fr) 1968-04-05
CH533124A (de) 1973-01-31
GB1186723A (en) 1970-04-02
DE1670684A1 (de) 1970-12-03

Similar Documents

Publication Publication Date Title
FR6681M (fr)
AU424443B2 (fr)
AU415165B1 (fr)
AU414526B2 (fr)
BE693439A (fr)
BE626310A (fr)
AU414093B2 (fr)
AU411645B2 (fr)
AU407778B2 (fr)
BE694389A (fr)
BE694293A (fr)
BE694221A (fr)
BE693791A (fr)
BE693644A (fr)
BE693488A (fr)
BE693428A (fr)
BE692765A (fr)
BE692532A (fr)
BE692471A (fr)
BE691644A (fr)
BE691006A (fr)
BE690378A (fr)
BE690073A (fr)
BE689764A (fr)
BE680880A (fr)